Literature DB >> 10652195

Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice.

L Roten1, S Nemoto, J Simsic, M L Coker, V Rao, S Baicu, G Defreyte, P J Soloway, M R Zile, F G Spinale.   

Abstract

Alterations in the expression and activity of the matrix metalloproteinases (MMPs) and the tissue inhibitors of the MMPs (TIMPs) have been implicated in tissue remodeling in a number of disease states. One of the better characterized TIMPs, TIMP-1, has been shown to bind to active MMPs and to regulate the MMP activational process. The goal of this study was to determine whether deletion of the TIMP-1 gene in mice, which in turn would remove TIMP-1 expression in LV myocardium, would produce time-dependent effects on LV geometry and function. Age-matched sibling mice (129Sv) deficient in the TIMP-1 gene (TIMP-1 knock-out (TIMP-1 KO), n=10) and wild-type mice (n=10) underwent comparative echocardiographic studies at 1 and 4 months of age. LV catheterization studies were performed at 4 months and the LV harvested for histomorphometric studies. LV end-diastolic volume and mass increased (18+/-4 and 38+/-3%, respectively, P<0.05) at 4 months in the TIMP-1 KO group; a significant increase compared to wild-type controls (P<0.05). At 4 months, LV and end-diastolic wall stress was increased by over two-fold in the TIMP-1 KO compared to wild type (P<0.05). However, LV systolic pressure and ejection performance were unchanged in the two groups of mice. LV myocyte cross-sectional area was unchanged in the TIMP-1 KO mice compared to controls, but myocardial fibrillar collagen content was reduced. Changes in LV geometry occurred in TIMP-1 deficient mice and these results suggest that constitutive TIMP-1 expression participates in the maintenance of normal LV myocardial structure. Copyright 2000 Academic Press.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; NASA Program Biomedical Research and Countermeasures; Non-NASA Center

Mesh:

Substances:

Year:  2000        PMID: 10652195     DOI: 10.1006/jmcc.1999.1052

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  29 in total

1.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

2.  Tissue inhibitor of metalloproteinase 1 regulates resistance to infection.

Authors:  Marie Mei Lee; Bong-June Yoon; Keith Osiewicz; Michael Preston; Brian Bundy; Anna M van Heeckeren; Zena Werb; Paul D Soloway
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

Review 4.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 5.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 6.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

7.  Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Li-Mien Chen; Mu-Hsin Chang; Wei-Kung Chen; Fuu-Jen Tsai; Chang-Hai Tsai; Tung-Yuan Lai; Wei-Wen Kuo; Chih-Yang Huang; Chung-Jung Liu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

8.  Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.

Authors:  William M Yarbrough; Catalin Baicu; Rupak Mukherjee; An Van Laer; William T Rivers; Richard A McKinney; Corey B Prescott; Robert E Stroud; Parker D Freels; Kia N Zellars; Michael R Zile; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

Review 9.  Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors:  J Thomas Peterson
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

10.  Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes.

Authors:  Sangeetha Chandrasekaran; Richard E Peterson; Santhosh K Mani; Benjamin Addy; Avery L Buchholz; Lin Xu; Thirumagal Thiyagarajan; Harinath Kasiganesan; Christine B Kern; Donald R Menick
Journal:  FASEB J       Date:  2009-07-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.